About Vivanza Biosciences Limited
Data last updated: 30 December 2025
Vivanza Biosciences Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 06 March 1982, the company has been in operation for over 44 years.
Registered with ROC Ahmedabad under CIN L24110GJ1982PLC005057. Listed on BSE: 530057.
Capital: an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. Formerly known as Ivee Injectaa Private Limited and Ivee Injectaa Limited. It is led by directors including Jainil Raseshkumar Bhatt and Hemant Amrish Parikh.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: 403 Sarthik 2 Opp. Rajpath Club S. G. Highway, Ahmedabad, Gujarat, India – 380054.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.48 Cr, a decline of 73% compared to the previous year.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Vivanza Biosciences. As per MCA filings, the company has open charges of ₹3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivanzabiosciences.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address403 Sarthik 2 Opp. Rajpath Club S. G. Highway, Ahmedabad, Gujarat, India – 380054
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Vivanza Biosciences Limited
Vivanza Biosciences Limited has undergone 2 name changes throughout its history. The company was previously known as Ivee Injectaa Private Limited, and Ivee Injectaa Limited. The current legal name is Vivanza Biosciences Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Vivanza Biosciences Limited | Current |
| Ivee Injectaa Private Limited | Previous |
| Ivee Injectaa Limited | Previous |
CIN History of Vivanza Biosciences Limited
Vivanza Biosciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24105GJ1982PLC005057, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24105GJ1982PLC005057 | Current |
| L24110GJ1982PLC005057 | Previous |
| U24110GJ1982PTC005057 | Previous |
Associated Brands with Vivanza Biosciences Limited
Vivanza Biosciences Limited operates one associated brand: Vivanza Biosciences. These brands represent Vivanza Biosciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and medical gloves are manufactured in India. | vivanzabiosciences.com |
Business Activity of Vivanza Biosciences Limited
Vivanza Biosciences Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Vivanza Biosciences Limited
Vivanza Biosciences Limited is audited by SHIVAM SONI & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHIVAM SONI & CO. | blur-value | blur-value | blur-value |
Board of Directors of Vivanza Biosciences Limited
Vivanza Biosciences Limited is currently managed by 7 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Jainil Raseshkumar Bhatt
Also directs:
Vivanta Industries Limited, Vivanza Lifesciences Private Limited, Mouser Venture Llp and 2 more
|
Cfo | 17 Jun 2016 | 10 Years 0 Months | Current |
| Hemant Amrish Parikh | Director | 29 Mar 2019 | 7 Years 3 Months | Current |
| Rina Kumari | Director | 30 Apr 2024 | 2 Years 2 Months | Current |
|
Jayendra Mehta
Also directs:
Vitaaglobal Bioscience Private Limited, Vital Interiors & Furnitures Private Limited, Vaishali Lifecare Private Limited and 1 more
|
Managing Director | 25 Apr 2023 | 3 Years 2 Months | Current |
| Sarang Bharat Pathak | Director | 30 Aug 2025 | 0 Years 10 Months | Current |
| Hitesh Pradeep Rijwani | Director | 12 May 2025 | 1 Years 1 Months | Current |
Financials of Vivanza Biosciences Limited FY 2026 filings available
Vivanza Biosciences Limited reported revenue of ₹115.91 Cr (up 1461.44% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹115.91 Cr | ₹7.42 Cr | ₹27.84 Cr | ₹17.81 Cr | ₹10.4 Cr | ₹9.89 Cr | ₹9.62 Cr | ₹2.66 Cr |
| Other Income | ₹11.15 Lakh | ₹6.15 Lakh | ₹5.42 Lakh | ₹47.54 Lakh | ₹82.88 Lakh | ₹50.56 Lakh | ₹57.04 Lakh | ₹0 |
| Total Income | ₹116.02 Cr | ₹7.48 Cr | ₹27.89 Cr | ₹18.28 Cr | ₹11.23 Cr | ₹10.39 Cr | ₹10.19 Cr | ₹2.66 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹115.71 Cr | ₹7.08 Cr | ₹25.48 Cr | ₹16.55 Cr | ₹11.43 Cr | ₹8.84 Cr | ₹8.26 Cr | ₹2.08 Cr |
| Changes in Inventories | -₹1.29 Cr | -₹25.68 Lakh | ₹46.83 Lakh | -₹4.65 Lakh | -₹1.77 Cr | ₹31.38 Lakh | ₹1.04 Cr | ₹27.87 Lakh |
| Employee Benefit Expense | ₹49.24 Lakh | ₹57.51 Lakh | ₹45.13 Lakh | ₹35.08 Lakh | ₹29.62 Lakh | ₹33.91 Lakh | ₹29.81 Lakh | ₹13.9 Lakh |
| Finance Costs | ₹27.92 Lakh | ₹35.14 Lakh | ₹41.3 Lakh | ₹41.86 Lakh | ₹40.56 Lakh | ₹46.76 Lakh | ₹43.51 Lakh | ₹41.85 Lakh |
| Depreciation & Amortisation | ₹2.16 Lakh | ₹1.4 Lakh | ₹1.21 Lakh | ₹26,000 | ₹74,000 | ₹98,000 | ₹0 | ₹0 |
| Other Expenses | ₹25.91 Lakh | ₹38.94 Lakh | ₹36.7 Lakh | ₹28.76 Lakh | ₹53.29 Lakh | ₹30.09 Lakh | ₹37.15 Lakh | ₹18.5 Lakh |
| Total Expenses | ₹115.48 Cr | ₹8.15 Cr | ₹27.19 Cr | ₹17.57 Cr | ₹10.9 Cr | ₹10.27 Cr | ₹10.4 Cr | ₹3.1 Cr |
| Profit Before Exceptional Items & Tax | ₹54.37 Lakh | -₹66.57 Lakh | ₹69.53 Lakh | ₹71.65 Lakh | ₹33.34 Lakh | ₹12.34 Lakh | -₹20.56 Lakh | -₹44.09 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹54.37 Lakh | -₹66.57 Lakh | ₹69.53 Lakh | ₹71.65 Lakh | ₹33.34 Lakh | ₹12.34 Lakh | -₹20.56 Lakh | -₹44.09 Lakh |
| Total Tax Expense | ₹14.94 Lakh | ₹84,000 | ₹14.79 Lakh | ₹11.81 Lakh | ₹4,000 | ₹4.89 Lakh | ₹0 | ₹0 |
| Net Profit | ₹39.43 Lakh | -₹67.41 Lakh | ₹54.74 Lakh | ₹59.84 Lakh | ₹33.3 Lakh | ₹7.45 Lakh | -₹20.56 Lakh | -₹44.09 Lakh |
| attributable to Owners | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | -₹44.09 Lakh |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 |
| Other Comprehensive Income | ₹0 | -₹67.41 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹39.43 Lakh | -₹1.35 Cr | ₹54.74 Lakh | ₹59.84 Lakh | ₹33.3 Lakh | ₹7.45 Lakh | -₹20.56 Lakh | -₹44.09 Lakh |
| EBITDA (computed) | ₹84.45 Lakh | -₹30.03 Lakh | ₹1.12 Cr | ₹1.14 Cr | ₹74.64 Lakh | ₹60.08 Lakh | ₹22.95 Lakh | -₹2.24 Lakh |
| Basic EPS | ₹0.10 | ₹-0.17 | ₹0.14 | ₹1.50 | ₹0.83 | ₹0.19 | ₹-0.51 | ₹-1.10 |
| Diluted EPS | ₹0.10 | ₹-0.17 | ₹0.14 | ₹1.50 | ₹0.83 | ₹0.19 | ₹-0.51 | ₹-1.10 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹22.09 Cr | ₹16.45 Cr | ₹19.5 Cr | ₹22.48 Cr | ₹12.83 Cr | ₹8.45 Cr | ₹12.36 Cr | ₹10.56 Cr |
| Non-current Assets | ₹3.03 Cr | ₹4.07 Cr | ₹3.76 Cr | ₹2.92 Cr | ₹3.11 Cr | ₹3.43 Cr | ₹3.22 Cr | ₹3.45 Cr |
| Current Assets | ₹19.05 Cr | ₹12.38 Cr | ₹15.74 Cr | ₹19.55 Cr | ₹9.72 Cr | ₹5.01 Cr | ₹9.14 Cr | ₹7.11 Cr |
| Property, Plant & Equipment | ₹80.13 Lakh | ₹69.88 Lakh | ₹70.49 Lakh | ₹67.95 Lakh | ₹68.21 Lakh | ₹68.95 Lakh | ₹67.82 Lakh | ₹67.82 Lakh |
| Inventories | ₹3.55 Cr | ₹2.26 Cr | ₹2.01 Cr | ₹2.47 Cr | ₹2.43 Cr | ₹65.35 Lakh | ₹96.74 Lakh | ₹2 Cr |
| Trade Receivables | ₹12.38 Cr | ₹8.06 Cr | ₹11.54 Cr | ₹12.48 Cr | ₹7.84 Cr | ₹6.25 Cr | ₹6.54 Cr | ₹5.15 Cr |
| Cash & Equivalents | ₹6.53 Lakh | ₹11.69 Lakh | ₹16.69 Lakh | ₹14.09 Lakh | -₹2.68 Cr | -₹3.09 Cr | -₹2.78 Cr | -₹3 Cr |
| Equity (Net Worth) | ₹4.36 Cr | ₹3.96 Cr | ₹4.64 Cr | ₹4.09 Cr | ₹3.49 Cr | ₹3.16 Cr | ₹3.08 Cr | ₹3.29 Cr |
| Equity Share Capital | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| Borrowings (Non-current) | ₹87.72 Lakh | ₹3.33 Cr | ₹2.68 Cr | ₹1.43 Cr | ₹2.6 Cr | ₹0 | ₹21.27 Lakh | ₹57.97 Lakh |
| Borrowings (Current) | ₹9.31 Cr | ₹5.32 Cr | ₹2.49 Cr | ₹6.56 Cr | ₹17.53 Lakh | ₹35.75 Lakh | ₹17.53 Lakh | ₹90.26 Lakh |
| Total Debt (computed) | ₹10.19 Cr | ₹8.65 Cr | ₹5.17 Cr | ₹8 Cr | ₹2.77 Cr | ₹35.75 Lakh | ₹38.8 Lakh | ₹1.48 Cr |
| Current Liabilities | ₹16.85 Cr | ₹9.15 Cr | ₹12.18 Cr | ₹16.95 Cr | ₹6.74 Cr | ₹5.29 Cr | ₹9.06 Cr | ₹6.69 Cr |
| Total Liabilities | ₹17.73 Cr | ₹12.49 Cr | ₹14.86 Cr | ₹18.39 Cr | ₹9.33 Cr | ₹5.29 Cr | ₹9.27 Cr | ₹7.27 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹1.26 Cr | -₹2.5 Cr | ₹2.04 Cr | -₹94.57 Lakh | ₹2.47 Cr |
| Investing Cash Flow | -₹5.21 Lakh | -₹79,000 | -₹3.75 Lakh | ₹0 | ₹0 |
| Financing Cash Flow | ₹1.26 Cr | ₹2.46 Cr | -₹1.98 Cr | ₹1.03 Cr | -₹2.06 Cr |
| Capital Expenditure | ₹12.4 Lakh | ₹79,000 | ₹3.75 Lakh | ₹0 | ₹0 |
| Free Cash Flow (computed) | -₹1.38 Cr | -₹2.51 Cr | ₹2.01 Cr | -₹94.57 Lakh | ₹2.47 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹5.16 Lakh | -₹4.99 Lakh | ₹2.59 Lakh | ₹8.58 Lakh | ₹41.15 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6.36 Cr | ₹45.25 Cr | ₹55.36 Cr | ₹8.94 Cr | ₹48.3 Lakh | ₹1.5 Cr | ₹3 Cr | ₹2.44 Cr |
| Other Income | ₹86,000 | ₹7.79 Lakh | ₹76,000 | ₹1.74 Lakh | ₹4.61 Lakh | ₹1.03 Lakh | ₹19,000 | ₹32,000 |
| Total Income | ₹6.37 Cr | ₹45.33 Cr | ₹55.37 Cr | ₹8.96 Cr | ₹52.91 Lakh | ₹1.51 Cr | ₹3 Cr | ₹2.44 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹5.96 Cr | ₹44.15 Cr | ₹55.99 Cr | ₹9.61 Cr | ₹47.79 Lakh | ₹1.47 Cr | ₹2.82 Cr | ₹2.3 Cr |
| Changes in Inventories | ₹56.01 Lakh | ₹76.43 Lakh | -₹1.56 Cr | -₹1.06 Cr | ₹69.56 Lakh | -₹36.43 Lakh | -₹11.03 Lakh | -₹47.91 Lakh |
| Employee Benefit Expense | ₹6.74 Lakh | ₹4.04 Lakh | ₹24.82 Lakh | ₹13.64 Lakh | ₹15.23 Lakh | ₹13.29 Lakh | ₹13.73 Lakh | ₹15.26 Lakh |
| Finance Costs | ₹6.58 Lakh | ₹8.97 Lakh | ₹4.71 Lakh | ₹7.66 Lakh | ₹7.98 Lakh | ₹8.72 Lakh | ₹9.15 Lakh | ₹9.29 Lakh |
| Depreciation & Amortisation | ₹1.1 Lakh | ₹35,000 | ₹35,000 | ₹35,000 | ₹28,000 | ₹41,000 | ₹41,000 | ₹30,000 |
| Other Expenses | ₹93,000 | ₹8.78 Lakh | ₹6.64 Lakh | ₹9.57 Lakh | ₹11.04 Lakh | ₹13.49 Lakh | ₹4.01 Lakh | ₹10.46 Lakh |
| Total Expenses | ₹6.67 Cr | ₹45.13 Cr | ₹54.8 Cr | ₹8.87 Cr | ₹1.52 Cr | ₹1.47 Cr | ₹2.99 Cr | ₹2.18 Cr |
| Profit Before Exceptional Items & Tax | -₹30.14 Lakh | ₹19.54 Lakh | ₹56.29 Lakh | ₹8.69 Lakh | -₹98.97 Lakh | ₹4.34 Lakh | ₹1.55 Lakh | ₹26.58 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹30.14 Lakh | ₹19.54 Lakh | ₹56.29 Lakh | ₹8.69 Lakh | -₹98.97 Lakh | ₹4.34 Lakh | ₹1.55 Lakh | ₹26.58 Lakh |
| Total Tax Expense | ₹14.94 Lakh | ₹0 | ₹0 | ₹0 | ₹84,000 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹45.08 Lakh | ₹19.54 Lakh | ₹56.29 Lakh | ₹8.69 Lakh | -₹99.81 Lakh | ₹4.34 Lakh | ₹1.55 Lakh | ₹26.58 Lakh |
| attributable to Owners | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | - | - |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | - | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | -₹99.81 Lakh | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹45.08 Lakh | ₹19.54 Lakh | ₹56.29 Lakh | ₹8.69 Lakh | -₹2 Cr | ₹4.34 Lakh | ₹1.55 Lakh | ₹26.58 Lakh |
| EBITDA (computed) | -₹22.46 Lakh | ₹28.86 Lakh | ₹61.35 Lakh | ₹16.7 Lakh | -₹90.71 Lakh | ₹13.47 Lakh | ₹11.11 Lakh | ₹36.17 Lakh |
| Basic EPS | ₹-0.11 | ₹0.05 | ₹0.14 | ₹0.02 | ₹-0.25 | ₹0.01 | ₹0.00 | ₹0.07 |
| Diluted EPS | ₹-0.11 | ₹0.05 | ₹0.14 | ₹0.02 | ₹-0.25 | ₹0.01 | ₹0.00 | ₹0.07 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹112.23 Cr | ₹2.94 Cr | ₹14.41 Cr | ₹14.21 Cr | ₹9.15 Cr | ₹9.22 Cr | ₹9.43 Cr | ₹2.22 Cr |
| Other Income | ₹10.94 Lakh | ₹3.46 Lakh | ₹5.42 Lakh | ₹38.68 Lakh | ₹82.81 Lakh | ₹49.98 Lakh | ₹53.35 Lakh | ₹0 |
| Total Income | ₹112.34 Cr | ₹2.98 Cr | ₹14.47 Cr | ₹14.59 Cr | ₹9.98 Cr | ₹9.72 Cr | ₹9.96 Cr | ₹2.22 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹112.07 Cr | ₹2.67 Cr | ₹13.17 Cr | ₹12.34 Cr | ₹10.31 Cr | ₹8.11 Cr | ₹8.08 Cr | ₹1.61 Cr |
| Changes in Inventories | -₹1.1 Cr | -₹4.29 Lakh | -₹18.95 Lakh | ₹61.52 Lakh | -₹1.83 Cr | ₹45.66 Lakh | ₹1.06 Cr | ₹37.24 Lakh |
| Employee Benefit Expense | ₹33.08 Lakh | ₹36.73 Lakh | ₹30.62 Lakh | ₹26.19 Lakh | ₹11.98 Lakh | ₹29.08 Lakh | ₹25.7 Lakh | ₹10.58 Lakh |
| Finance Costs | ₹27.92 Lakh | ₹35.08 Lakh | ₹41.3 Lakh | ₹41.82 Lakh | ₹40.56 Lakh | ₹46.76 Lakh | ₹43.51 Lakh | ₹41.85 Lakh |
| Depreciation & Amortisation | ₹2.16 Lakh | ₹1.4 Lakh | ₹1.21 Lakh | ₹26,000 | ₹74,000 | ₹98,000 | ₹0 | ₹0 |
| Other Expenses | ₹22.27 Lakh | ₹31.42 Lakh | ₹32.27 Lakh | ₹26.83 Lakh | ₹49.73 Lakh | ₹24.42 Lakh | ₹33.91 Lakh | ₹16.23 Lakh |
| Total Expenses | ₹111.82 Cr | ₹3.67 Cr | ₹14.04 Cr | ₹13.91 Cr | ₹9.51 Cr | ₹9.58 Cr | ₹10.17 Cr | ₹2.67 Cr |
| Profit Before Exceptional Items & Tax | ₹51.78 Lakh | -₹69.37 Lakh | ₹42.9 Lakh | ₹68.72 Lakh | ₹46.41 Lakh | ₹14.8 Lakh | -₹20.38 Lakh | -₹44.9 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹51.78 Lakh | -₹69.37 Lakh | ₹42.9 Lakh | ₹68.72 Lakh | ₹46.41 Lakh | ₹14.8 Lakh | -₹20.38 Lakh | -₹44.9 Lakh |
| Total Tax Expense | ₹14.29 Lakh | ₹14,000 | ₹11.15 Lakh | ₹11.81 Lakh | ₹4,000 | ₹4.81 Lakh | ₹0 | ₹0 |
| Net Profit | ₹37.49 Lakh | -₹69.51 Lakh | ₹31.75 Lakh | ₹56.91 Lakh | ₹46.37 Lakh | ₹9.99 Lakh | -₹20.38 Lakh | -₹44.9 Lakh |
| Other Comprehensive Income | ₹0 | -₹69.51 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹37.49 Lakh | -₹1.39 Cr | ₹31.75 Lakh | ₹56.91 Lakh | ₹46.37 Lakh | ₹9.99 Lakh | -₹20.38 Lakh | -₹44.9 Lakh |
| EBITDA (computed) | ₹81.86 Lakh | -₹32.89 Lakh | ₹85.41 Lakh | ₹1.11 Cr | ₹87.71 Lakh | ₹62.54 Lakh | ₹23.13 Lakh | -₹3.05 Lakh |
| Basic EPS | ₹0.09 | ₹-0.17 | ₹0.08 | ₹1.42 | ₹1.16 | ₹0.25 | ₹-0.51 | ₹-1.12 |
| Diluted EPS | ₹0.09 | ₹-0.17 | ₹0.08 | ₹1.42 | ₹1.16 | ₹0.25 | ₹-0.51 | ₹-1.12 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹18.23 Cr | ₹13.91 Cr | ₹16.87 Cr | ₹20.44 Cr | ₹11.47 Cr | ₹7.93 Cr | ₹12.28 Cr | ₹10.29 Cr |
| Non-current Assets | ₹2.63 Cr | ₹2.53 Cr | ₹2.54 Cr | ₹2.51 Cr | ₹2.51 Cr | ₹2.52 Cr | ₹2.51 Cr | ₹2.51 Cr |
| Current Assets | ₹15.59 Cr | ₹11.38 Cr | ₹14.33 Cr | ₹17.93 Cr | ₹8.96 Cr | ₹5.41 Cr | ₹9.77 Cr | ₹7.78 Cr |
| Property, Plant & Equipment | ₹12.31 Lakh | ₹2.06 Lakh | ₹2.67 Lakh | ₹13,000 | ₹38,000 | ₹1.13 Lakh | ₹0 | ₹0 |
| Inventories | ₹2.95 Cr | ₹1.84 Cr | ₹1.8 Cr | ₹1.61 Cr | ₹2.23 Cr | ₹39.77 Lakh | ₹85.43 Lakh | ₹1.91 Cr |
| Trade Receivables | ₹10.66 Cr | ₹7.39 Cr | ₹10.37 Cr | ₹12.18 Cr | ₹7.35 Cr | ₹6.11 Cr | ₹6.41 Cr | ₹4.99 Cr |
| Cash & Equivalents | ₹1.78 Lakh | ₹4.94 Lakh | ₹9.05 Lakh | ₹10.45 Lakh | -₹2.72 Cr | -₹3.11 Cr | -₹2.81 Cr | -₹3.03 Cr |
| Equity (Net Worth) | ₹4.4 Cr | ₹4.02 Cr | ₹4.72 Cr | ₹4.4 Cr | ₹3.83 Cr | ₹3.37 Cr | ₹3.27 Cr | ₹3.47 Cr |
| Equity Share Capital | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| Borrowings (Non-current) | ₹87.72 Lakh | ₹77.53 Lakh | ₹77.53 Lakh | ₹0 | ₹1.68 Cr | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹6.62 Cr | ₹5.32 Cr | ₹2.49 Cr | ₹6.56 Cr | ₹0 | ₹17.53 Lakh | ₹17.53 Lakh | ₹90.26 Lakh |
| Total Debt (computed) | ₹7.5 Cr | ₹6.09 Cr | ₹3.26 Cr | ₹6.56 Cr | ₹1.68 Cr | ₹17.53 Lakh | ₹17.53 Lakh | ₹90.26 Lakh |
| Current Liabilities | ₹12.95 Cr | ₹9.12 Cr | ₹11.38 Cr | ₹16.04 Cr | ₹0 | ₹4.57 Cr | ₹9.01 Cr | ₹6.82 Cr |
| Total Liabilities | ₹13.83 Cr | ₹9.89 Cr | ₹12.16 Cr | ₹16.04 Cr | ₹7.64 Cr | ₹4.57 Cr | ₹9.01 Cr | ₹6.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹1.21 Cr | -₹2.47 Cr | ₹1.8 Cr | ₹16.09 Lakh | -₹67.72 Lakh |
| Investing Cash Flow | ₹5.48 Lakh | -₹79,000 | -₹3.75 Lakh | ₹0 | ₹0 |
| Financing Cash Flow | ₹1.13 Cr | ₹2.44 Cr | -₹1.77 Cr | -₹7.53 Lakh | ₹1.07 Cr |
| Capital Expenditure | ₹12.4 Lakh | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | -₹1.34 Cr | -₹2.47 Cr | ₹1.8 Cr | ₹16.09 Lakh | -₹67.72 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹3.16 Lakh | -₹4.11 Lakh | -₹1.39 Lakh | ₹8.56 Lakh | -₹2.72 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹5.75 Cr | ₹44.93 Cr | ₹53.73 Cr | ₹7.82 Cr | ₹16.96 Lakh | ₹76.21 Lakh | ₹1.58 Cr | ₹42.78 Lakh |
| Other Income | ₹77,000 | ₹7.67 Lakh | ₹76,000 | ₹1.74 Lakh | ₹1.92 Lakh | ₹1.03 Lakh | ₹19,000 | ₹32,000 |
| Total Income | ₹5.75 Cr | ₹45.01 Cr | ₹53.74 Cr | ₹7.84 Cr | ₹18.88 Lakh | ₹77.24 Lakh | ₹1.59 Cr | ₹43.1 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹5.34 Cr | ₹43.87 Cr | ₹55.16 Cr | ₹7.71 Cr | ₹17.18 Lakh | ₹75.35 Lakh | ₹1.42 Cr | ₹32.13 Lakh |
| Changes in Inventories | ₹42.38 Lakh | ₹76.43 Lakh | -₹2.13 Cr | -₹15.63 Lakh | ₹69.69 Lakh | -₹29.05 Lakh | -₹4.52 Lakh | -₹40.41 Lakh |
| Employee Benefit Expense | ₹3.84 Lakh | ₹4.04 Lakh | ₹15.98 Lakh | ₹9.22 Lakh | ₹11.25 Lakh | ₹7.38 Lakh | ₹8.74 Lakh | ₹9.36 Lakh |
| Finance Costs | ₹6.58 Lakh | ₹8.97 Lakh | ₹4.71 Lakh | ₹7.66 Lakh | ₹7.92 Lakh | ₹8.72 Lakh | ₹9.15 Lakh | ₹9.29 Lakh |
| Depreciation & Amortisation | ₹1.1 Lakh | ₹35,000 | ₹35,000 | ₹35,000 | ₹28,000 | ₹41,000 | ₹41,000 | ₹30,000 |
| Other Expenses | ₹22,000 | ₹8.53 Lakh | ₹4.12 Lakh | ₹9.4 Lakh | ₹8.97 Lakh | ₹10.57 Lakh | ₹2.1 Lakh | ₹9.78 Lakh |
| Total Expenses | ₹5.88 Cr | ₹44.85 Cr | ₹53.28 Cr | ₹7.82 Cr | ₹1.15 Cr | ₹73.38 Lakh | ₹1.58 Cr | ₹20.45 Lakh |
| Profit Before Exceptional Items & Tax | -₹12.31 Lakh | ₹16.05 Lakh | ₹46.21 Lakh | ₹1.85 Lakh | -₹96.41 Lakh | ₹3.86 Lakh | ₹53,000 | ₹22.65 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹12.31 Lakh | ₹16.05 Lakh | ₹46.21 Lakh | ₹1.85 Lakh | -₹96.41 Lakh | ₹3.86 Lakh | ₹53,000 | ₹22.65 Lakh |
| Total Tax Expense | ₹14.29 Lakh | ₹0 | ₹0 | ₹0 | ₹14,000 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹26.6 Lakh | ₹16.05 Lakh | ₹46.21 Lakh | ₹1.85 Lakh | -₹96.55 Lakh | ₹3.86 Lakh | ₹53,000 | ₹22.65 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | -₹96.54 Lakh | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹26.6 Lakh | ₹16.05 Lakh | ₹46.21 Lakh | ₹1.85 Lakh | -₹1.93 Cr | ₹3.86 Lakh | ₹53,000 | ₹22.65 Lakh |
| EBITDA (computed) | -₹4.63 Lakh | ₹25.37 Lakh | ₹51.27 Lakh | ₹9.86 Lakh | -₹88.21 Lakh | ₹12.99 Lakh | ₹10.09 Lakh | ₹32.24 Lakh |
| Basic EPS | ₹-0.07 | ₹0.04 | ₹0.12 | ₹0.01 | ₹-0.24 | ₹0.01 | ₹0.00 | ₹0.06 |
| Diluted EPS | ₹-0.07 | ₹0.04 | ₹0.12 | ₹0.01 | ₹-0.24 | ₹0.01 | ₹0.00 | ₹0.06 |
Shareholding Pattern of Vivanza Biosciences Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 20.02%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 79.98% of Vivanza Biosciences Limited. The company had 19,461 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% |
| Public | 79.98% | 79.98% | 79.98% | 79.98% | 79.98% | 79.98% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 20.02% | 20.02% | 43.24% |
| Public | 79.98% | 79.98% | 56.76% |
| Promoter change (YoY, %pts) | +0.00 | -23.22 | - |
Group Structure of Vivanza Biosciences Limited
Vivanza Biosciences Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Vivanza Biosciences Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Vivanza Lifesciences Private Limited | U15549GJ2003PTC042592 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Vivanza Biosciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2017 | State Bank of India | ₹3 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Vivanza Biosciences Limited
View historical data on people associated with Vivanza Biosciences Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Vivanza Biosciences Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vivanza Biosciences Limited
GSTIN & GST Filing Data of Vivanza Biosciences Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vivanza Biosciences Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vivanza Biosciences Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vivanza Biosciences Limited
MSME Payment Delays by Vivanza Biosciences Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vivanza Biosciences Limited
Subsidiaries & Group Companies of Vivanza Biosciences Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vivanza Biosciences Limited with ownership details.
MCA Filings & Documents of Vivanza Biosciences Limited
MCA Filings & Documents of Vivanza Biosciences Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vivanza Biosciences Limited
Recent News on Vivanza Biosciences Limited
Frequently Asked Questions about Vivanza Biosciences Limited
Vivanza Biosciences Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 06 March 1982 (44+ years old) and is registered under CIN L24105GJ1982PLC005057. Listed on BSE: 530057.
Vivanza Biosciences Limited reported revenue of ₹7.48 Cr for FY 2025 (down 73.00% YoY).
The current directors of Vivanza Biosciences Limited are:
The primary industry of Vivanza Biosciences Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes. Vivanza Biosciences Limited is listed on BSE with code 530057.
Vivanza Biosciences Limited can be reached at the registered office: 403 Sarthik 2 Opp. Rajpath Club S. G. Highway, Ahmedabad, Gujarat, India – 380054, or through the website vivanzabiosciences.com.